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Retrospective Tests of B-Cold Lymphocytotoxins and 
Transplant Survival at a Single Center 
Y. Iwaki, P. I. Terasaki, R. Weil, L. Koep, and T. Starzl 
I N A PREVIOUS study we showed that patients who have antibodies reactive to B 
lymphocytes in the cold have a higher kidney 
transplant survival rate than patients with no 
preformed cytotoxins.' This result is of poten-
tial importance because antibodies to B 
lymphocytes may possibly be detecting 
enhancing antibodies. Such antibodies that 
help a transplant are particularly relevant 
because of the recent finding that immuniza-
tion by transfusion results in higher trans-
plant survival rates.' In order to reexamine 
this finding, sera from over 203 patients from 
a single transplantation center were tested. 
The previous study had been based on 
patients accumulated from 27 centers. It was 
hoped that a more uniform treatment of these 
patients and the increased numbers of cases 
would either confirm or refute the earlier 
findings. 
MATERIALS AND METHODS 
Frozen serum samples stored at - 80°C for periods up 
to 7 years from 203 recipients were investigated. The 
samples were taken within I week prior to transplanta-
tion. Of the transplants. 129 were grafts from cadaver 
donors. and 74 were one-haplotype·identical related 
transplants. Transplants from H LA-identical sibling 
donors were disregarded for this study. 
The isolation and testing of Band T lymphocytes have 
been described.' All sera were tested under three condi-
tions: that is, B lymphocytes at 5°C and Band T 
lymphocytes at 37°e. 
The sera were divided into three types of reaction 
patterns (Table I). The B-cold pattern consisted of 
reactions of B lymphocytes at 5°C and negative reactions 
for Band T lymphocytes at 37°e. The B-warm pattern 
was defined as reactions of B lymphocytes at both 
temperatures with no reactions of T lymphocytes at 
37°e. The T·warm pattern was defined as a reaction with 
B lymphocytes at both temperatures and T lymphocytes 
at 37°e. 
RESULTS 
Of the 203 sera tested. 21 (10.3%) showed 
the B-cold pattern, 29 (14%) showed the 
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B-warm pattern, and 15 (7%) showed the 
T-warm pattern; the remaining 138 patients 
(68%) did not react with either T or B 
lymphocytes. These percent~ges of distribu-
tion for the four different categories of 
patients are quite similar to those obtained in 
two earlier studies. 14 Thus there is some 
assurance that storing sera in different ways 
over fairly long periods of time did not signif-
icantly change the types of antibody detect-
able in the sera. It should be noted, however, 
that our earlier study also dealt with sera 
stored as long as 3 years. 
As shown in Fig. 1, patients who had 
antibodies to B lymphocytes in the cold had a 
higher transplant survival rate at 1 year 
(80%) than patients with no antibodies 
(69%). The difference is admittedly small, 
and the number of patients with the B-cold 
antibody pattern is limited. 
The differences among the four categories 
of patients with cadaver-donor transplants 
were marked (Fig. 2). Those patients with the 
B-cold pattern had a I-year survival rate of 
82%, as compared with 58% for patients with 
no antibodies (p<O.07). Those with the B-
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Table 1. Three Reaction Patterns and Their Specificities 
Reaction 
P.nero B 4'C B 37"C T 37'C Specificity 
B-cold + Non-HLA 
S-warm + + HLA-A. -S. -C. -DR 
T-warm + + + HLA-A. -B.-C 
warm and T-warm patterns had 37% and 36% 
survival. respectively. at 1 year. 
DISCUSSION 
In comparison with our previous study. the 
general results of this study from a single 
center are quite similar. In this series the 
patients with antibodies reactive to B lympho-
cytes only in the cold had higher transplant 
survival rates. Among related-donor trans-
plants the difference in survival rate was not 
significant in either study. With the cadaver-
donor transplants a significant difference was 
found in this study as well as in the study 
reported previously. It should be noted that an 
independent study of patients from the Mayo 
Clinic also confirmed the original observa-
tion_ S In that study the B-cold pattern was 
found to be significantly associated with 
prolonged survival in the recipients with 
related donors but not in the recipients with 
cadaver donors. 
In the current investigation the patients 
who had preformed warm cytotoxins to either 
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Fig. 1. Actuarial graft survival for one-haplotype-
matched related transplants according to type of 
preformed cytotoxins. 
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Fig. 2_ Actuarial graft survival for cadaver-donor trans-
plants according to type of pre transplant cytotoxins. 
B or T lymphocytes were noted to have a 
lower graft survival rate than those with no 
cytotoxins. Thi5 lower survival rate can be 
attributed either to the fact that those 
patients who make antibodies were more 
responsive or to the fact that weak positive 
cross-matches or latent positive cross-matches 
were not detected in these patients. 
It is also important to note that positive 
cross-matches to B lymphocytes should be 
divided into the two categories" for cytotoxins 
active in the cold that are not deleterious. 
whereas those reactive in the warm appear to 
be associated with low transplant survival 
rates. It seems now that warm B-cell cvtotox-
ins are directed against HLA-DR. or i~ many 
instances against HLA-A, -B, and -C spec-
ificities.? HLA-A, -B, and -C antibodies that 
are too weak to react against T lymphocytes 
have now been shown to react to B lympho-
cytes. Thus a positive cross-match to B cells 
reactive in the warm would be assumed to be 
a contraindication to transplantation. Many 
of the transplants with positive B-cell cross-
matches that have functioned may have been 
in patients with non- H LA antibodies reactive 
in the cold 8 - 11 
The present retrospective studies suggest 
that the cold antibodies to B lymphocytes can 
be monitored, particularly after such treat-
ment as transfusions, to determine the ideal 
state prior to transplantation. Following blood 
transfusions, the monitoring of patients with 
antibodies to Band T lymphocytes may be 
-8-COLD L YMPHOCYTOTOXINS 
important in knowing when to stop the immu-
nization and when to continue it. 
SUMMARY 
Sera from 203 recipients prior to transplan-
tation were examined against a panel of 30 T 
and B lymphocytes at SoC and 37°C. Those 
patients classified as having B-cold cytotoxins 
only had higher I-year transplant survival 
rates from cadaver donors (82%) than 
943 
patients with no antibodies (58%) or patients 
with antibodies reactive to T and B lympho-
cytes in the warm (37%). These results based 
on transplants from a single center confirm 
earlier studies derived from patients in 27 
centers. 
ACKNOWLEDGMENT 
The authors wish to acknowledge the excellent techni-
cal assistance of Simon Prince, Mark Hermes, Larry 
Cardman, and Yoshi Arai. 
REFERENCES 
I. Iwaki Y, Terasaki PI. Park MS. et al: Lancet 
1:1228.1978 
2. Opelz G. Terasaki PI: N Engl J Med 299:799. 
1978 
3. Terasaki PI. Bernoco D. Park MS. et al: Am J Clin 
PathoI69:103.1978 
4. Ayoub GM. Terasaki PI. lwaki Y: Dial Transplant 
7:496. 1978 
5. Moore B. Terasaki PI. Iwaki Y: (submitted) 
6. Iwaki Y. Terasaki PI. Hermes M L: Transplanta-
tion and Clinical Immunology. vol 9. Amsterdam. 
Excerpta 1I.1edica. 1977. P 91 
7. Iwaki Y. Terasaki PI. Park MS. et al: Transplant 
Proc (this issue) 
8. Ettenger RB. Terasaki PI. Opelz G: Lancet 2:56. 
1976 
9. Lobo PI. Westervelt FB. Rudolf LE: Lancet 1:925. 
1977 
10. Morris PJ. Ting A. Oliver DO. et al: Lancet 
1:1288.1977 
II. Suthanthiran M. Gailiunas P. Person A. et al: 
Transplant Proc 10:471. 1978 
4¥ 
